Transcutaneous Bilirubinometers in the Community - NCT00735319-Stony Plain - 005 (Clinical Trial 236640)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy236640.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Stony Plain |
|
Country:
|
|
Canada |
|
|
|
| Conditions: |
|
Jaundice, Neonatal |
| Purpose: |
|
Jaundice is the most frequent reason for readmission for healthy newborns after discharge
from the nursery. In the Capital Health area, around 2.5% (315 babies in 2005) of all
healthy newborns were admitted to the hospital for jaundice. Although jaundice is very
common, it is not always a benign condition. If left untreated, it can have devastating
consequences including cerebral palsy and hearing loss. It is therefore critical to be able
to identify the newborns at risk for severe jaundice. So far, heel puncture of blood
collection has been the traditional method to monitor jaundice in newborns. This causes pain
to infants, generates anxiety in parents, and consumes significant health care resources.
The aim of this study is to evaluate the efficacy of a new and noninvasive screening tool,
the transcutaneous bilirubinometer, in detecting babies in our communities who require
hospital readmission. This study will demonstrate whether incorporating transcutaneous
bilirubinometer in the home care program delivered by nurses of Healthy Beginning allows the
early detection of babies at risk of developing severe jaundice at a lower cost and with
less discomfort.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- All near term (35 and 36 weeks gestational age) and term (37 to 41 weeks) babies
living in Alberta Capital Health (CH) region
- Born at any Capital Health or Caritas delivery facility(Royal Alexandra Hospital,
Grey Nuns Community Hospital, Misericordia Community Hospital, Sturgeon Community
Hospital, Fort Saskatchewan Health Centre, and WestView Health Centre)
- Discharged home from the nursery within 96 hours of life
Exclusion Criteria:
- Babies who do not live in CH region
- Babies born at less than 35 weeks gestational age
- Babies initially admitted to a Special Care Nursery (SCN) or a Neonatal Intensive
Care unit (NICU) for more than 72 hours
- Babies born to opting-out mothers will also be excluded |
|
|
|
| Study is available at: |
|
WestView Health Centre
Stony Plain
Canada
Primary Contact:
Thierry Lacaze, MD PhD FRCPC
Email: Thierry.Lacaze@albertahealthservices.ca
Phone: (780) 407-1178 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 4, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|